DK0996636T3 - HA-1-antigenet - Google Patents
HA-1-antigenetInfo
- Publication number
- DK0996636T3 DK0996636T3 DK98936758T DK98936758T DK0996636T3 DK 0996636 T3 DK0996636 T3 DK 0996636T3 DK 98936758 T DK98936758 T DK 98936758T DK 98936758 T DK98936758 T DK 98936758T DK 0996636 T3 DK0996636 T3 DK 0996636T3
- Authority
- DK
- Denmark
- Prior art keywords
- cells
- tumor cells
- hematopoietic
- derivatives
- peptide
- Prior art date
Links
- 108010091373 HA-1 antigen Proteins 0.000 title 1
- 101001081189 Homo sapiens Rho GTPase-activating protein 45 Proteins 0.000 abstract 7
- 102100027748 Rho GTPase-activating protein 45 Human genes 0.000 abstract 7
- 210000004881 tumor cell Anatomy 0.000 abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 208000019691 hematopoietic and lymphoid cell neoplasm Diseases 0.000 abstract 2
- 208000009329 Graft vs Host Disease Diseases 0.000 abstract 1
- 210000001744 T-lymphocyte Anatomy 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 238000010322 bone marrow transplantation Methods 0.000 abstract 1
- 210000001151 cytotoxic T lymphocyte Anatomy 0.000 abstract 1
- 238000002405 diagnostic procedure Methods 0.000 abstract 1
- 210000002919 epithelial cell Anatomy 0.000 abstract 1
- 208000024908 graft versus host disease Diseases 0.000 abstract 1
- 201000005787 hematologic cancer Diseases 0.000 abstract 1
- 208000024200 hematopoietic and lymphoid system neoplasm Diseases 0.000 abstract 1
- 238000009169 immunotherapy Methods 0.000 abstract 1
- 208000032839 leukemia Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 210000000056 organ Anatomy 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 238000002054 transplantation Methods 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70539—MHC-molecules, e.g. HLA-molecules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/10—Cellular immunotherapy characterised by the cell type used
- A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/20—Cellular immunotherapy characterised by the effect or the function of the cells
- A61K40/22—Immunosuppressive or immunotolerising
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
- A61K40/41—Vertebrate antigens
- A61K40/418—Antigens related to induction of tolerance to non-self
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
- A61K40/41—Vertebrate antigens
- A61K40/42—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Transplantation (AREA)
- Hematology (AREA)
- Communicable Diseases (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP97202303 | 1997-07-23 | ||
| PCT/NL1998/000424 WO1999005173A1 (en) | 1997-07-23 | 1998-07-23 | The ha-1 antigen |
| EP98936758A EP0996636B1 (en) | 1997-07-23 | 1998-07-23 | The ha-1 antigen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0996636T3 true DK0996636T3 (da) | 2005-04-25 |
Family
ID=8228585
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK98936758T DK0996636T3 (da) | 1997-07-23 | 1998-07-23 | HA-1-antigenet |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US6878375B1 (da) |
| EP (1) | EP0996636B1 (da) |
| JP (1) | JP2001510851A (da) |
| AT (1) | ATE287900T1 (da) |
| AU (2) | AU8564098A (da) |
| CA (1) | CA2298887A1 (da) |
| DE (1) | DE69828791T2 (da) |
| DK (1) | DK0996636T3 (da) |
| ES (1) | ES2236924T3 (da) |
| PT (1) | PT996636E (da) |
| WO (2) | WO1999005173A1 (da) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2298887A1 (en) * | 1997-07-23 | 1999-02-04 | Rijksuniversiteit Te Leiden | The ha-1 antigen |
| US20040092446A1 (en) * | 1997-07-23 | 2004-05-13 | Goulmy Elsa A.J.M. | HA-1 epitopes and uses thereof |
| AU2002218019A1 (en) * | 2000-11-03 | 2002-05-15 | Nexell Therapeutics Inc. | Methods for depleting and isolating alloreactive and antigen-reactive t cells from hematopoietic donor cells |
| EP1317927A1 (en) * | 2001-12-05 | 2003-06-11 | Academisch Ziekenhuis Leiden | Minor histocompatibility antigen HA-1: target antigen for immunotherapy of tumors |
| AU2016218902A1 (en) * | 2015-02-09 | 2017-08-10 | Rsem, Limited Partnership | Novel minor histocompatibility antigens and uses thereof |
| WO2018058002A1 (en) * | 2016-09-23 | 2018-03-29 | Fred Hutchinson Cancer Research Center | Tcrs specific for minor histocompatibility (h) antigen ha-1 and uses thereof |
| JP7406990B2 (ja) * | 2016-11-11 | 2023-12-28 | ホワイトヘッド・インスティテュート・フォー・バイオメディカル・リサーチ | ヒト血漿様培地 |
| CA3054089A1 (en) * | 2017-02-22 | 2018-08-30 | Universite De Montreal | Novel minor histocompatibility antigens and uses thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5770201A (en) | 1994-12-23 | 1998-06-23 | Rijsuniversiteit Te Leiden | HA-2 antigenic peptide |
| AU716907B2 (en) * | 1995-07-25 | 2000-03-09 | Rijksuniversiteit Te Leiden | HA-2 antigenic peptide |
| NZ313774A (en) * | 1995-07-27 | 1999-11-29 | Univ Leiden | The h-y antigen |
| WO1997004798A1 (en) | 1995-07-28 | 1997-02-13 | University Of Virginia Patent Foundation | H-y derived epitopes and uses therefor |
| CA2298887A1 (en) | 1997-07-23 | 1999-02-04 | Rijksuniversiteit Te Leiden | The ha-1 antigen |
| ATE315103T1 (de) | 1997-07-23 | 2006-02-15 | Univ Leiden | Verfahren zur typisierung des ha-1 nebenhistokompatibilitätsantigens |
| EP0965648A1 (en) | 1998-06-02 | 1999-12-22 | Rijksuniversiteit Leiden | Method for genomic typing of the Minor Histocomptability Antigen HA-1. |
| EP1170589A1 (en) | 2000-06-05 | 2002-01-09 | Stichting Sanquin Bloedvoorziening | Method for histocompatibility testing |
| EP1317927A1 (en) | 2001-12-05 | 2003-06-11 | Academisch Ziekenhuis Leiden | Minor histocompatibility antigen HA-1: target antigen for immunotherapy of tumors |
-
1998
- 1998-07-23 CA CA002298887A patent/CA2298887A1/en not_active Abandoned
- 1998-07-23 EP EP98936758A patent/EP0996636B1/en not_active Expired - Lifetime
- 1998-07-23 AU AU85640/98A patent/AU8564098A/en not_active Abandoned
- 1998-07-23 JP JP2000504165A patent/JP2001510851A/ja active Pending
- 1998-07-23 DE DE69828791T patent/DE69828791T2/de not_active Expired - Fee Related
- 1998-07-23 WO PCT/NL1998/000424 patent/WO1999005173A1/en not_active Ceased
- 1998-07-23 ES ES98936758T patent/ES2236924T3/es not_active Expired - Lifetime
- 1998-07-23 AU AU85639/98A patent/AU756962B2/en not_active Ceased
- 1998-07-23 PT PT98936758T patent/PT996636E/pt unknown
- 1998-07-23 WO PCT/NL1998/000425 patent/WO1999005174A1/en not_active Ceased
- 1998-07-23 DK DK98936758T patent/DK0996636T3/da active
- 1998-07-23 AT AT98936758T patent/ATE287900T1/de not_active IP Right Cessation
-
2000
- 2000-01-21 US US09/489,760 patent/US6878375B1/en not_active Expired - Fee Related
-
2004
- 2004-03-02 US US10/791,217 patent/US7205119B2/en not_active Expired - Fee Related
-
2007
- 2007-02-20 US US11/708,723 patent/US20080206268A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| PT996636E (pt) | 2005-05-31 |
| AU8564098A (en) | 1999-02-16 |
| ATE287900T1 (de) | 2005-02-15 |
| US6878375B1 (en) | 2005-04-12 |
| ES2236924T3 (es) | 2005-07-16 |
| US20080206268A1 (en) | 2008-08-28 |
| JP2001510851A (ja) | 2001-08-07 |
| DE69828791D1 (de) | 2005-03-03 |
| US7205119B2 (en) | 2007-04-17 |
| WO1999005174A1 (en) | 1999-02-04 |
| AU8563998A (en) | 1999-02-16 |
| WO1999005173A1 (en) | 1999-02-04 |
| AU756962B2 (en) | 2003-01-30 |
| EP0996636A1 (en) | 2000-05-03 |
| CA2298887A1 (en) | 1999-02-04 |
| EP0996636B1 (en) | 2005-01-26 |
| DE69828791T2 (de) | 2006-01-12 |
| US20040191268A1 (en) | 2004-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Yoshino et al. | HER2/neu-derived peptides are shared antigens among human non-small cell lung cancer and ovarian cancer | |
| EA200501206A1 (ru) | Производные от сурвивина пептиды и их применение | |
| Yee et al. | Modulating T-cell immunity to tumours: new strategies for monitoring T-cell responses | |
| WO1999004265A3 (en) | Cancer associated nucleic acids and polypeptides | |
| PT1734049E (pt) | Peptídeos associados a tumores de ligação à molécula mhc | |
| DK0810870T3 (da) | Isolerede, MAGE-2-afledte tumorafstødelsesantigenpræcurserpeptider og anvendelse heraf | |
| US11981944B2 (en) | Immunogenic arginase peptides | |
| Kobayashi et al. | Defining MHC class II T helper epitopes for WT1 tumor antigen | |
| AU2003267401A1 (en) | Novel mhc ii associated peptides | |
| DK0996636T3 (da) | HA-1-antigenet | |
| Hueman et al. | Analysis of naive and memory CD4 and CD8 T cell populations in breast cancer patients receiving a HER2/neu peptide (E75) and GM-CSF vaccine | |
| WO2020127546A3 (en) | Immunotherapy with b*08 restricted peptides and combination of peptides against cancers and related methods | |
| BR0012446A (pt) | Proteìna da rede de leitura alternativa do receptory de células t e uso da mesma | |
| Slingluff | Targeting unique tumor antigens and modulating the cytokine environment may improve immunotherapy for tumors with immune escape mechanisms | |
| AU5409996A (en) | Ha-2 antigenic peptide | |
| DK1444261T3 (da) | Immunogene ALK (anaplastisk lymfomakinase) peptider | |
| Parmiani et al. | Tumor immunology: molecularly defined antigens and clinical applications | |
| CO5300468A1 (es) | Antigeno asociado con tumores | |
| Ouyang et al. | Induced Pluripotent Stem Cell-Based | |
| WO2004011496A3 (en) | Novel t-cell proteins, peptides and antibodies derived therefrom and uses thereof | |
| EA202191411A1 (ru) | Иммунотерапия раковых заболеваний рестриктированными по b*08 пептидами и комбинациями пептидов и связанные с ними способы | |
| AU2001281943A1 (en) | The t-cell protein (tzon7), peptides and antibodies derived therefrom and uses thereof | |
| DK1560848T3 (da) | PTPRK-immunogent peptid |